From Intentions to Outcomes: Rethinking Impact in Healthcare
Intro

On 26 October, we hosted the first session of our new Community of Practice in Healthcare, centred around the LIFe framework. Developed by a coalition of impact investors, including Achmea IM, CbusineZ, Invest-NL, PGGM and VGZ, the framework provides a shared language and structure for defining, measuring and comparing impact across healthcare ventures and investments.

Leonie Delsink (VGZ) and Vicky van Heck (Achmea IM) opened the discussion by exploring how LIFe helps investors and entrepreneurs align impact goals. They were joined by Karen Berg of Healthy.Capital, and Tijntje Louwers of MiGuide, who shared their experiences on implementing the framework. Together, the panel reflected on the role of impact measurement and management in strengthening impact investing within the Dutch healthcare ecosystem.
Framework and Early-Stage Investing
The Life Sciences and Healthcare Impact framework (LIFe) supports investors to evaluate potential impact before making an investment, and monitor progress over time by comparing expected and realised outcomes.
Learn more here.

The framework provides six dimensions which allows investors to determine which are most relevant to a specific investment opportunity. Its primary purpose is to track activities, monitor outcomes, and assess performance by comparing expected and realised impact. It provides a practical and accessible way to measure impact in healthcare investments.
LIFe can be applied across the investment lifecycle, from early-stage ventures to more mature, scaling businesses. At the beginning, when companies have a limited track record but can demonstrate impact through trials, the framework allows investors to assess performance against the most relevant dimensions rather than requiring evidence across all six.
As companies mature and build a stronger evidence base, investment decisions can draw on the full framework. This ensures that promising innovations are not overlooked simply because they are still at an early stage of development.
Panel session
The panel discussion demonstrated that the LIFe Framework can serve both as a strategic tool for investors and as a practical way to communicate impact to external stakeholders. Rather than replacing existing due diligence processes, participants agreed that LIFe complements them by providing a structured approach to assessing and managing impact throughout the investment lifecycle.
The framework can support both investment selection and reporting. Investors can use it to incorporate impact considerations into investment decisions and monitor progress over time. However, the panel noted that comparing the absolute impact of different investments remains challenging due to the limited availability of sector-wide benchmark data.
Another contributing factor is that the framework does not prescribe a fixed set of KPIs. While this may limit direct comparisons, it is also one of LIFe's strengths, a one-size-fits-all framework would be difficult to apply in practice. The LIFe framework offers a flexible use-case to bring comparability amongst investments, allowing better informed investment decisions to be made faster.
A key strength of the framework is its function as a feedback loop. By comparing expected impact at the time of investment with realised outcomes, investors can test assumptions, refine their approach and improve future decision-making. This shifts the focus from simply measuring outputs to understanding the quality and scale of the outcomes achieved.
In a healthcare ecosystem shaped by many actors, attributing impact to a single investor requires a cautious approach. The panel noted that assessing true impact requires comparison against a credible baseline or status quo scenario, which is not currently embedded in the framework. While LIFe could evolve to incorporate this, concerns were raised about the feasibility of standardised controls.
Finally, the discussion highlighted that trade-offs between the framework's six dimensions are often unavoidable. Few investments generate positive outcomes across all dimensions simultaneously, making it important to assess potential negative effects alongside positive ones. By encouraging investors to consider both intended and unintended consequences, the LIFe Framework helps create a more balanced and credible approach to impact measurement and management in healthcare.
We are grateful to VGZ, Achmea, Healthy.Capital, and MiGuide for their contributions. By sharing their expertise and experiences, they helped bring the LIFe Framework to life and offered valuable insights into how it can enhance the credibility and transparency of healthcare impact investing.
This was the first in a series of events within our Healthcare Community of Practice focusing on the LIFe framework. The NAB will support the further development of this framework, wider dissemination and adoption across ecosystems.
Missed the session or want another look at the slides?